πŸ‡ΊπŸ‡Έ FDA
Patent

US 10774122

ERG targeted therapy

granted A61KA61K38/00A61K47/542

Quick answer

US patent 10774122 (ERG targeted therapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K47/542, A61K47/60, A61K47/64